Tue. 20 Feb 2024, 11:38am ET
Benzinga
Biotech, News, Eurozone, Markets, General
NexImmune Has Received A Decision To Grant European Patent Number EP3970748 Titled "Nanoparticle Compositions And Methods For Immunotherapy"
Company Profile